Toolkit/CRISPR interference

CRISPR interference

Construct Pattern·Research·Since 2017

Also known as: CRISPRi

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

CRISPR interference (CRISPRi) ... can silence or reactivate genes in a programmable, non-mutational manner, offering a new route to reverse resistance or sensitize pathogens.

Usefulness & Problems

Why this is useful

CRISPRi is described as a programmable approach that can silence genes without changing the DNA sequence. In this review context, it is positioned as a way to manipulate bacterial resistance-associated regulation.; programmable gene silencing in bacteria; non-mutational manipulation of resistance-associated regulatory layers; pathogen sensitization to antibiotics; CRISPR interference is presented as a functional tool for systems metabolic engineering in amino acid producing strains. In this review context it is used for genetic control rather than being described as a specific product pathway.; systems metabolic engineering; genetic regulation of amino acid producing strains

Source:

CRISPRi is described as a programmable approach that can silence genes without changing the DNA sequence. In this review context, it is positioned as a way to manipulate bacterial resistance-associated regulation.

Source:

programmable gene silencing in bacteria

Source:

non-mutational manipulation of resistance-associated regulatory layers

Source:

pathogen sensitization to antibiotics

Source:

CRISPR interference is presented as a functional tool for systems metabolic engineering in amino acid producing strains. In this review context it is used for genetic control rather than being described as a specific product pathway.

Source:

systems metabolic engineering

Source:

genetic regulation of amino acid producing strains

Problem solved

It offers a route to reverse resistance or sensitize pathogens by directly controlling gene expression at regulatory layers.; provides programmable control of gene expression without altering DNA sequence; The review includes CRISPR interference among approaches intended to address current limitations of metabolic engineering.; addresses current limitations of metabolic engineering

Source:

It offers a route to reverse resistance or sensitize pathogens by directly controlling gene expression at regulatory layers.

Source:

provides programmable control of gene expression without altering DNA sequence

Source:

The review includes CRISPR interference among approaches intended to address current limitations of metabolic engineering.

Source:

addresses current limitations of metabolic engineering

Problem links

addresses current limitations of metabolic engineering

Literature

The review includes CRISPR interference among approaches intended to address current limitations of metabolic engineering.

Source:

The review includes CRISPR interference among approaches intended to address current limitations of metabolic engineering.

provides programmable control of gene expression without altering DNA sequence

Literature

It offers a route to reverse resistance or sensitize pathogens by directly controlling gene expression at regulatory layers.

Source:

It offers a route to reverse resistance or sensitize pathogens by directly controlling gene expression at regulatory layers.

Published Workflows

Objective: Connect natural bacterial methylome and broader epigenetic regulation insights to programmable CRISPR-based epigenetic editing strategies for reversing resistance or sensitizing pathogens.

Why it works: The abstract presents a logic in which methylome mapping and multi-omics profiling identify reversible regulatory mechanisms underlying tolerance and resistance, and CRISPR-based tools then provide programmable, non-mutational access to manipulate those same layers.

DNA methylationRNA methylationhistone-like protein regulationsmall non-coding RNA regulationepigenetic plasticitysingle-molecule sequencingmethylome mappingCRISPR interferencedCas9-fused methyltransferase editingmulti-omics integration

Stages

  1. 1.
    Methylome and epigenetic state mapping(functional_characterization)

    This stage exists to identify reversible epigenetic systems associated with virulence, efflux, stress response, and antibiotic survival before attempting intervention.

    Selection: Use single-molecule sequencing and methylome mapping to uncover DNA methyltransferase systems and associated regulatory patterns.

  2. 2.
    Multi-omics integration(secondary_characterization)

    This stage exists to connect methylation patterns to broader expression and protein-level consequences relevant to tolerance and resistance.

    Selection: Integrate methylomic data with transcriptomic and proteomic profiles to reveal how epigenetic plasticity sustains antimicrobial tolerance across environments.

  3. 3.
    Programmable CRISPR-based epigenetic intervention(confirmatory_validation)

    This stage exists to directly manipulate the regulatory layers identified upstream and test whether they can be used to reverse resistance or sensitize pathogens.

    Selection: Apply CRISPRi or dCas9-fused methyltransferases to silence or reactivate genes in a programmable, non-mutational manner.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Techniques

No technique tags yet.

Target processes

editingtranscription

Input: Light

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: sensor

Implementation requires CRISPR interference components in the host strain. The abstract does not specify nuclease variants, guide design rules, or delivery details.; requires CRISPR interference machinery

The abstract does not state which targets, hosts, or production phenotypes are most suitable, nor any failure modes.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1tool capabilitysupports2025Source 1needs review

CRISPRi can silence genes in a programmable, non-mutational manner and is presented as a route to reverse resistance or sensitize pathogens.

Claim 2tool capabilitysupports2025Source 1needs review

dCas9-fused methyltransferases can silence or reactivate genes in a programmable, non-mutational manner and are presented as a route to reverse resistance or sensitize pathogens.

Claim 3toolkit overviewsupports2017Source 2needs review

Recent systems metabolic engineering approaches to address current limitations of metabolic engineering include genome reduction, amino acid sensors based on transcriptional regulators and riboswitches, CRISPR interference, small regulatory RNAs, DNA scaffolding, and optogenetic control.

Approval Evidence

2 sources2 linked approval claimsfirst-pass slug crispr-interference
CRISPR interference (CRISPRi) ... can silence or reactivate genes in a programmable, non-mutational manner, offering a new route to reverse resistance or sensitize pathogens.

Source:

To address current limitations of metabolic engineering, this article gives insights on recent systems metabolic engineering approaches based on functional tools and method such as genome reduction, amino acid sensors based on transcriptional regulators and riboswitches, CRISPR interference...

Source:

tool capabilitysupports

CRISPRi can silence genes in a programmable, non-mutational manner and is presented as a route to reverse resistance or sensitize pathogens.

Source:

toolkit overviewsupports

Recent systems metabolic engineering approaches to address current limitations of metabolic engineering include genome reduction, amino acid sensors based on transcriptional regulators and riboswitches, CRISPR interference, small regulatory RNAs, DNA scaffolding, and optogenetic control.

Source:

Comparisons

Source-stated alternatives

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.; The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Source:

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Source:

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Source-backed strengths

programmable; non-mutational; highlighted as a recent functional tool and method

Source:

programmable

Source:

non-mutational

Source:

highlighted as a recent functional tool and method

Compared with CRISPR/Cas9

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Compared with CRISPR/Cas9 system

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Compared with CRISPRi/a

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract contrasts CRISPRi with dCas9-fused methyltransferase approaches as another programmable CRISPR-based way to manipulate epigenetic regulation.

Compared with DNA scaffolding

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Compared with optogenetic

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Compared with small regulatory RNAs

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Shared frame: source-stated alternative in extracted literature

Strengths here: programmable; non-mutational; highlighted as a recent functional tool and method.

Source:

The abstract lists genome reduction, amino acid sensors, small regulatory RNAs, DNA scaffolding, and optogenetic control as alternative or complementary tools.

Ranked Citations

  1. 1.
    StructuralSource 1MED2025Claim 1Claim 2

    Seeded from load plan for claim c4. Extracted from this source document.

  2. 2.
    StructuralSource 2Bioresource Technology2017Claim 3

    Seeded from load plan for claim cl4. Extracted from this source document.